These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24094190)

  • 1. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
    Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S; Souto EB; Silva AM
    Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.
    Yin H; Zhang H; Liu B
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):634-40. PubMed ID: 23786839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and in vitro cytotoxicity assay of curcumin loaded solid lipid nanoparticle in IMR32 neuroblastoma cell line.
    Rahman MH; Ramanathan M; Sankar V
    Pak J Pharm Sci; 2014 Sep; 27(5):1281-5. PubMed ID: 25176384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H; Geng D; Liu H; Li Z; Cao J
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
    Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.
    Zhuang YG; Xu B; Huang F; Wu JJ; Chen S
    Pharmazie; 2012 Nov; 67(11):925-9. PubMed ID: 23210242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
    Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.
    Zhu R; Cheng KW; Mackenzie G; Huang L; Sun Y; Xie G; Vrankova K; Constantinides PP; Rigas B
    Pharm Res; 2012 Nov; 29(11):3090-101. PubMed ID: 22723123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
    Han Y; Zhang P; Chen Y; Sun J; Kong F
    Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
    Huang WT; Larsson M; Wang YJ; Chiou SH; Lin HY; Liu DM
    Mol Pharm; 2015 Apr; 12(4):1242-9. PubMed ID: 25760774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptotic effect of curcumin loaded solid lipid nanoparticles.
    Vandita K; Shashi B; Santosh KG; Pal KI
    Mol Pharm; 2012 Dec; 9(12):3411-21. PubMed ID: 23127155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
    Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.